We are a Biomedical Company specialized in Medical Nutrition,
founded in 2007 in Barcelona (Spain), we develop activities of research, development, innovation, marketing and licensing-out of new nutraceuticals and functional foods.
Our great value is the investigation and we firmly believe in the alliance between “Company-University”, developing our activities in two R&D&i centers.
From our production plant we offer our nutraceuticals products in different gastro-resistant formats (tablets, pellets, micropellets, capsules, microcapsules and nanocapsules), facilitating the adaptation to the current regulations of each market and their marketing on an international scale.
We also develop In Vitro molecular diagnostic kits.
DAO LEADER PRODUCER
DR Healthcare stands out for being a leader in production of Diamine Oxidase,
what allows us to offer tailored solutions for use in the veterinary, animal health and food sectors.
Our solutions based on Diamine Oxidase are adapted to new laws and standards in food control, which stipulate the control of the levels of histamine in order to avoid the risk of intoxication due to the consumption of high amounts of this biogenic amine present in food.
Veterinary solutions based on diamine oxidase to prevent the histaminosis in domestic animals, livestock and aquaculture. Their health is that of all being vital to avoid the pathophysiological effects that trigger high levels of histamine.
FAO and WHO and countries around the world have implemented regulations that include the analysis of those foods that may contain high levels of histamine and measures to prevent their production through a correct preservation, processing and distribution.
specialists in DAO deficiency
DAO deficiency is an alteration in the metabolism of food histamine that occurs when there is little activity of the enzyme diamine oxidase (DAO). The DAO is the main enzyme in the metabolism of exogenous histamine and begins its functional activity in the intestine.
When exists a disproportion between the histamine swallowed or released by the cells that store it in the body, and the ability to metabolize it, there is the accumulation of histamine in plasma and the appearance of adverse effects.
A deficit in the metabolic activity of diamine oxidase can be due to genetic, pharmacological and pathological factors.
main symptoms in DAO DEFICIENCY
Migraine, fibromyalgia, irritable bowel syndrome (IBS) and the attention deficit-hyperactivity disorder (ADHD) are the symptoms with higher prevalences in the world population caused by DAO deficiency.
Actuality about DAO deficiency
News in media and press releases
Scientific and clinical evidence
Association of Diamine oxidase (DAO) variants with the risk for migraine from North Indian population
Activities and events on DAO deficiency